Abstract Background The community pharmacy medicines use review (MUR) service in England has been identified as a way of providing support with medication to recently discharged patients; however initial uptake of postdischarge MUR has been low. Objective To identify barriers to recruitment into a randomised controlled feasibility study of a hospital referral system to older patients' regular community pharmacists. Method Ward pharmacists at Southport District General Hospital identified patients aged over 65 to be approached by a researcher to assess eligibility and discuss involvement in the trial. Participants were randomised to referral for a post discharge MUR with their regular community pharmacist, or to standard discharge care. Reasons for patients not participating were collected. Results Over a 9-month period 337 potential participants were identified by ward pharmacists. Of these, 132 were eligible and 60 were recruited. Barriers to recruitment included competing priorities among ward pharmacists, and national restrictions placed on MURs e.g. housebound patients and those requiring carer support with medication. Lack of expected benefit resulted in a high proportion of patient refusals. Conclusion The current provisions for post discharge MURs exclude many older people from participation, including those possibly in greatest need. Unfamiliarity with the role of the pharmacist in transitional care may have affected patients' perceived 'costbenefit' of taking part in this study.
Introduction
The likelihood that an older medical patient will be discharged from hospital on the same medication they were admitted on is less than 10 %, and this extensive medication regimen modification may predispose to an increased risk of mortality [1] .
Improved discharge information and patient education are core principles for reducing unintentional medication changes, patient harm and hospital re-admissions [2, 3] . In the UK, a national service known as Medicines Use Reviews (MUR) is offered by many community pharmacists which is free to patients and paid for centrally by the NHS. The MUR is a face-to-face consultation between a patient and pharmacist, designed to identify any problems or information needs patients have with their medicines and offer solutions [4] . Since 2011, the MUR service has targeted specific patient groups, identified as being at particular risk of medication related problems or poor adherence, including patients recently discharged from hospital [4] . However, early evidence suggests uptake of post discharge MURs (dMURs) has been poor; pilot studies have shown that \3 % of patients 'signposted' to the service by hospital pharmacy staff receive a dMUR [5] .
In 2012, a Department of Health steering group recommended that formal communication channels between hospital and community pharmacy should be established so that dMURs become an integral part of the medicines pathway [2] . However, at present, most NHS hospital Trusts do not appear to have such formalised systems in place [6] .
Aim
To identify barriers to recruitment into a randomised controlled feasibility study of a hospital referral system to older patients' regular community pharmacists, and identify areas for improvement of the service or study design.
Ethical approval
Ethics approval for the study was obtained from the Northwest Research Ethics Committee (Ref 13/NW/0779).
Method
All pharmacists working on medical wards at Southport and Ormskirk NHS Trust, England were asked to identify patients over the age of 65 years who in their professional opinion might benefit from receiving a dMUR. These patients were referred on to the researcher (HR), who visited each patient on the wards to assess eligibility.
Inclusion criteria (all must be met for eligibility)
1. Taking at least one long-term medication prior to admission 2. Taking five or more medicines OR one or more changes to medication during hospital stay 3. Patient's community pharmacy signed up to received referrals from the hospital pharmacy.
Exclusion criteria The researcher approached eligible patients to discuss involvement in the study and provide an information leaflet. Patients were given up to 24 h (or longer if requested) to consider participation. Reasons for refusal were collected via verbal discussion, entered into an Excel spreadsheet and categorised by the researcher. Consenting patients were randomised to receive a dMUR at their regular community pharmacy or standard hospital discharge care (no formal communication with the patient's community pharmacy, unless the patient received their medication in a weekly compliance aid (monitored dosage system) in which case a discharge list of medication was faxed to the community pharmacy, usually within 24 h of discharge).
Prior to discharge each patient was told which group they had been assigned to, so they knew whether or not to expect their community pharmacist to contact them to arrange a dMUR.
Results
The study took place between 7th April 2014 and 6th January 2015. Over this 9-month period 337 potential participants were identified by ward pharmacists, which ultimately resulted in 60 patients recruited to the study, as shown in Fig. 1 .
The reasons for exclusion and refusal are displayed in Table 1 .
Discussion
This study is the first to describe formalising secondary care discharge of older patients into a nationally contracted community pharmacy service (dMURs) as advocated by UK health officials and bodies representing pharmacy.
Over the study period over 10,000 patients over 65 years of age were admitted to the hospital; clearly a very small proportion (3.2 %) of these patients were identified by ward pharmacists and referred on to the researcher. This highlights the pivotal role ward staff play in such studies as identified by McMurdo et al. [7] in their review of recruitment of older people to research. The low referral rate was despite steps taken by the researcher to raise awareness of the study among ward pharmacists, including a 'briefing' session prior to its commencement and posters displayed around the pharmacy department detailing types
of patients who might be suitable. A study 'pack' was also given to each pharmacist, containing background information about the study and its eligibility criteria. Additionally, email reminders were sent regularly to all ward pharmacists throughout the recruitment period. Feedback from ward pharmacists (n = 7) via a focus group highlighted that identification of patients for inclusion into any type of trial was not standard practice, thus not part of their daily routine and was therefore often forgotten about. Other barriers identified by the pharmacists were time constraints and concerns over patients' poor health status. Further investigation of these barriers and possible solutions (for example, increased pharmacist time on wards to allow for patient screening or use of information technology to make referral easier) is ongoing.
Patient exclusions
The most frequent reason (30.8 %) for ineligibility was patients' not self-medicating at home. This has implications for the English service specification for dMURs, which stipulates they must be conducted with the patient and not a care giver, unless the patient specifically consents for the carer to be present. In fact, patients requiring carers (Table 1) 60 recruited 72 refused (Table 1) 10682 medical paƟents aged 65+ admiƩed Fig. 1 Summary of recruitment phase of study Belief that medicines information will automatically be transferred to community pharmacy 1 (1.4 %) a The number of reasons for refusal is greater than the number of patients refusing, as some patients gave more than one reason to manage their medication may be more in need of a medication support service, as polypharmacy, including the use of inappropriate medication, is common among older populations who have 'managed care at home' [8] .
The nature of the nationally agreed service specification for community pharmacists also accounted for a relatively high proportion of patients (n = 22, 24.2 % of exclusions) being excluded from the study due to being housebound and unable to attend a community pharmacy for a dMUR. Only around one in 10 community pharmacies in this study were able to provide domiciliary visits. Mobility issues are obviously a key consideration in this population; reduced mobility due to ill health or availability of transport has been cited by others as a challenge to the recruitment of older patients [7, 9] .
Twenty patients (22 % of exclusions), were not well enough to engage in discussion with the researcher at the time of contact, either because they were too unwell (n = 9) or had cognitive impairment (n = 11). Delirium or other conditions may temporarily impair older patients' capacity, but they may recover by the point of discharge [7] . Therefore some patients may require more than one visit to properly engage with them regarding research.
Patient refusals
Of those patients fully screened, 72 (32 %) refused. This is within the range (8-54 %) found by McMurdo, and similar to a study of a pharmacist-led medication review clinic for older patients in primary care (36 %) [7, 10] .
The key reason for non-participation was patients saw no benefit in having a dMUR with their local community pharmacist (n = 20, 27.8 %). A further six patients (8.3 %) stated specifically that they would rather see their GP to discuss the changes to their medication. This indicates that the concept of the dMUR was either not fully understood by these patients, or not viewed as a useful service for them.
Fourteen (19.4 %) patients did not want to be involved in 'research'. Distrust of researchers and a reluctance to change their normal routine in order to take part in research have been cited elsewhere as a challenge in the recruitment of frail older patients [10] .
Eleven patients (15.3 %) expressed concern over time commitment that the study imposed. Beyond the dMUR itself, the study included two subsequent follow-up postal questionnaires, up to 6 months after the initial discharge. Patients may have viewed this commitment too burdensome, although comments from these patients (such as 'I've got enough appointments') also suggested that even the initial referral for a dMUR was too onerous. Again, an unfamiliarity with the role of the pharmacist in provision of transitional care may have affected the perceived 'costbenefit' of taking part in this study.
However, it appears that old age, per se, may not have been a barrier to participation (only 2 patients (1.5 %) said this was the reason for not taking part), but rather the frailty and co-morbidity that may accompany it (11 patients (15.3 %) declined due to 'health reasons'). This is consistent with research done by others [7, 10] . This potentially biases the study sample toward those patients who are more 'well' and thus may be less in need of a medication review.
Conclusion
This study has demonstrated that recruitment of older people to a study of a post discharge medicines support service provided by community pharmacists is difficult for a number of reasons. Patient unwillingness to participate, either due to ill-health or perceived lack of benefit were noted. Additionally, pertinent to this study, the current provisions in England for post discharge MURs excluded many people from participation, including those who were possibly in greatest need.
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